Anthem Biosciences IPO Allotment Status, Listing Date, and Grey Market Premium (GMP) – A Guide for Indian Investors
The Anthem Biosciences IPO, a leading Contract Research, Development, and Manufacturing Organisation (CRDMO) in the pharmaceutical space, concluded its subscription period on July 16. In this article, we will provide an update on the IPO allotment status, listing date, and grey market premium (GMP) for Indian investors.
Anthem Biosciences IPO Subscription and Allotment Status
The IPO received an overwhelming response from investors, with the overall subscription standing at 63.86 times the issue size. The Qualified Institutional Buyers (QIBs) booked their quota 182.65 times, Non-Institutional Investors (NIIs) subscribed 42.36 times, and retail investors 5.64 times, as per the National Stock Exchange (NSE) data.
The IPO allotment status is scheduled to be finalised on July 17, after which the company will transfer shares to the Demat accounts of investors and process refunds on July 18.
How to Check Anthem Biosciences IPO Allotment Status?
Investors can check their allotment status through the following official channels:
- Visit the NSE IPO allotment status page and follow the steps mentioned below:
- Select ‘Equity IPO’ under issue type.
- Choose ‘ANTHEM’ from the list of company symbols.
- Enter your IPO application number and PAN.
- Click ‘Submit’ to view your allotment status.
- Go to the Bombay Stock Exchange (BSE) website and select the issue type as ‘Equity’. Choose ‘Anthem Biosciences Limited’ from the dropdown menu, enter your application number or PAN, complete the ‘Captcha’ for verification, and click on the ‘Search’ button to view your allotment status.
- Visit KFin Technologies’ website and follow the steps mentioned below:
- Select any one of the five links on the homepage.
- Select ‘Anthem Biosciences’ in the IPO name section.
- Choose application number, Demat, or PAN.
- Submit the details and enter the captcha.
- View your allotment status.
Anthem Biosciences IPO Grey Market Premium (GMP)
The latest grey market premium (GMP) for Anthem Biosciences IPO stood at Rs 144 per share at 9:30 a.m. on July 17. This suggests a listing gain of 25.26% against the upper limit of the issue price. As per the latest GMP, shares of the company are expected to be listed at Rs 714 apiece.
It is essential to note that the GMP does not represent official data and is based on speculation.
What to Expect After Listing?
After the listing, shares of Anthem Biosciences will be available for trading on the BSE and NSE on July 21. The company will transfer shares to the Demat accounts of investors and process refunds on July 18.
Disclaimer
Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
